尿検査市場- 世界の産業規模、シェア、動向、競合、ビジネスチャンス、予測、製品タイプ別、用途別、エンドユーザー別、地域別、競合別、2020-2030年

尿検査の世界市場は、2024年には43億9,000万米ドルと評価され、2030年には68億4,000万米ドルに達し、CAGR 7.67％で成長すると予測されています。

この成長は、糖尿病や腎障害などの慢性疾患の有病率の増加が主な要因です。尿検査は、尿の物理的、化学的、顕微鏡的特性を調べる診断法で、尿路感染症、腎臓病、糖尿病などのさまざまな健康状態を検出・監視します。非侵襲的で有益な検査法として、尿検査は早期診断や疾病管理の分野で脚光を浴びています。さらに、泌尿器や腎臓の健康に対する一般市民の意識の高まりは、政府支援やヘルスケア投資の増加と相まって、先進国市場と新興国市場の両方においてアクセス性を高め、需要を促進しています。

市場促進要因

慢性疾患の増加

主な市場課題

規制遵守と品質管理

主要市場動向

ポイントオブケア検査へのシフト

目次

第1章 製品別概要

• 市場の定義
• 市場の範囲
  • 対象となる市場。
  • 調査対象年
  • 主要市場セグメンテーション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 尿検査市場見通し。

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（消耗品・器具）
  • 検査の種類別（妊娠・不妊検査、尿生化学検査、尿沈渣検査）
  • 用途別（疾病スクリーニングおよび妊娠・不妊治療）
  • エンドユーザー別（診断研究所、病院・診療所、在宅ケア施設、調査研究所・研究機関）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 アジア太平洋地域の尿検査市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国。
  • インド。
  • 韓国
  • 日本
  • オーストラリア

第7章 欧州の尿検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 北米の尿検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米の尿検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの尿検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品開発別

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威/サービス

第14章 尿検査市場：SWOT分析

第15章 競合情勢

• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Abbott Laboratories
• Cardinal Health Inc.
• Danaher Corporation
• Sysmex Corporation
• Quidel Corporation
• Becton, Dickinson & Company
• Bio-Rad Laboratories Inc.
• EKF Diagnostics Holdings plc

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Urinalysis Market was valued at USD 4.39 billion in 2024 and is projected to reach USD 6.84 billion by 2030, growing at a CAGR of 7.67%. This growth is largely driven by the increasing prevalence of chronic diseases such as diabetes and kidney disorders. Urinalysis is a diagnostic method that examines the physical, chemical, and microscopic properties of urine to detect and monitor a range of health conditions, including urinary tract infections, kidney disease, and diabetes. As a non-invasive and informative testing approach, urinalysis is gaining prominence in early diagnosis and disease management. Additionally, rising public awareness about urinary and kidney health, combined with increased government support and healthcare investment, is enhancing accessibility and fueling demand across both developed and developing markets.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The global rise in chronic conditions-particularly diabetes and chronic kidney disease (CKD)-is a major factor accelerating the growth of the urinalysis market. Urinalysis is a non-invasive, affordable diagnostic tool that plays a critical role in early detection, ongoing monitoring, and treatment planning for these diseases.

According to the World Health Organization (WHO), the global population aged 60 and above is expected to reach 2.1 billion by 2050, significantly increasing the incidence of age-related illnesses such as diabetes and CKD. The International Diabetes Federation noted that 537 million adults were living with diabetes in 2021, with projections indicating this figure will rise to 643 million by 2030. Urinalysis enables detection of biomarkers like glucose, ketones, and protein in urine, making it essential for effective management and timely intervention.

Key Market Challenges

Regulatory Compliance and Quality Control

The urinalysis market faces significant regulatory and quality assurance challenges. Manufacturers must meet stringent requirements imposed by bodies such as the FDA and EMA, which involve comprehensive product testing, documentation, and adherence to Good Manufacturing Practices (GMP). These compliance processes can be time-consuming and financially demanding.

Ensuring consistency in product performance across production batches is crucial, as any variation can compromise diagnostic accuracy. This necessitates rigorous quality control mechanisms and ongoing surveillance. For example, under the FDA's Medical Device Reporting (MDR) regulation, manufacturers are required to report device-related adverse events, ensuring constant monitoring and safety validation. These high standards increase the operational burden, potentially limiting market entry for smaller players and slowing innovation due to the associated costs and complexities.

Key Market Trends

Shift Towards Point-of-Care Testing

A major trend in the urinalysis market is the transition toward point-of-care testing (POCT), driven by the need for rapid diagnostics and decentralized healthcare services. POCT enables immediate testing and results interpretation at the site of care, which enhances clinical responsiveness and patient outcomes.

Urinalysis has emerged as a key area within POCT, thanks to the development of portable, easy-to-use devices that can be deployed in clinics, emergency rooms, and even at home. These devices offer fast analysis of urine parameters like glucose, protein, and leukocytes, facilitating prompt diagnosis and treatment.

Government support has further strengthened this trend. For instance, the Centers for Medicare & Medicaid Services (CMS) in the U.S. have introduced reimbursement policies that encourage POCT use in primary care. During health crises such as the COVID-19 pandemic, regulatory bodies also accelerated the approval of POCT devices to expand diagnostic capacity, underscoring the growing role of POCT in the future of healthcare.

Key Market Players

• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Abbott Laboratories
• Cardinal Health Inc.
• Danaher Corporation
• Sysmex Corporation
• Quidel Corporation
• Becton, Dickinson & Company
• Bio-Rad Laboratories Inc.
• EKF Diagnostics Holdings plc

Report Scope:

In this report, the Global Urinalysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Urinalysis Market, By Product:

• Consumables
• Instruments

Urinalysis Market, By Test Type:

• Pregnancy & Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

Urinalysis Market, By Application:

• Disease Screening
• Pregnancy & Fertility

Urinalysis Market, By End User:

• Diagnostic Laboratories
• Hospitals & Clinics
• Home Care Settings
• Research Laboratories & Institutes

Urinalysis Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Urinalysis Market.

Available Customizations:

Global Urinalysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. By Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Urinalysis Market Outlook.

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables & Instruments)
  • 5.2.2. By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis)
  • 5.2.3. By Application (Disease Screening and Pregnancy & Fertility)
  • 5.2.4. By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. Asia-Pacific Urinalysis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Test Type
  • 6.2.3. By Application
  • 6.2.4. By End user
  • 6.2.5. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Urinalysis Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Test Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End user
  • 6.3.2. India Urinalysis Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Test Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End user
  • 6.3.3. South Korea Urinalysis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Test Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End user
  • 6.3.4. Japan Urinalysis Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By Test Type
      • 6.3.4.2.3. By Application
      • 6.3.4.2.4. By End user
  • 6.3.5. Australia Urinalysis Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By Test Type
      • 6.3.5.2.3. By Application
      • 6.3.5.2.4. By End user

7. Europe Urinalysis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Test Type
  • 7.2.3. By Application
  • 7.2.4. By End user
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Urinalysis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Test Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End user
  • 7.3.2. Germany Urinalysis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Test Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End user
  • 7.3.3. United Kingdom Urinalysis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Test Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End user
  • 7.3.4. Italy Urinalysis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Test Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End user
  • 7.3.5. Spain Urinalysis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Test Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End user

8. North America Urinalysis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Test Type
  • 8.2.3. By Application
  • 8.2.4. By End user
  • 8.2.5. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Urinalysis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Test Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End user
  • 8.3.2. Mexico Urinalysis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Test Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End user
  • 8.3.3. Canada Urinalysis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Test Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End user

9. South America Urinalysis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Test Type
  • 9.2.3. By Application
  • 9.2.4. By End user
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Urinalysis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Test Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End user
  • 9.3.2. Argentina Urinalysis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End user
  • 9.3.3. Colombia Urinalysis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Test Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End user

10. Middle East and Africa Urinalysis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Test Type
  • 10.2.3. By Application
  • 10.2.4. By End user
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Urinalysis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Test Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End user
  • 10.3.2. Saudi Arabia Urinalysis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Test Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End user
  • 10.3.3. UAE Urinalysis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Test Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. By Product Developments

13. Porters Five Forces Analysis

• 1.1. Competition in the Industry
• 1.2. Potential of New Entrants
• 1.3. Power of Suppliers
• 1.4. Power of Customers
• 1.5. Threat of Substitute Products/Services

14. Urinalysis Market: SWOT Analysis

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. By Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Siemens Healthineers AG
• 15.3. Abbott Laboratories
• 15.4. Cardinal Health Inc.
• 15.5. Danaher Corporation
• 15.6. Sysmex Corporation
• 15.7. Quidel Corporation
• 15.8. Becton, Dickinson & Company
• 15.9. Bio-Rad Laboratories Inc.
• 15.10. EKF Diagnostics Holdings plc

16. Strategic Recommendations

17. About Us & Disclaimer